Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

aurobindo pharma news

Tag: aurobindo pharma news

Read all Latest developments, information and news on and about Aurobindo Pharmaceuticals - Page 3

Aurobindo Pharma is a pharmaceutical manufacturing company headquartered in Hyderabad manufacturing generic pharmaceuticals and active pharmaceutical ingredients. - Latest Updates

Laurus Labs gets USFDA EIR for Atchutapuram facility

Aurobindo Pharma step-down arm AP facility gets product approval from USFDA

Ruchika Sharma12 Sept 2024 11:40 AM IST

Telangana: Aurobindo Pharma has announced that the new injectable facility of Eugia Steriles Private Limited , a 100% subsidiary of Eugia Pharma...

Aurobindo Pharma arm pulled up by USFDA over manufacturing lapses at Telangana plant

Ruchika Sharma26 Aug 2024 2:30 PM IST

New Delhi: Aurobindo Pharma's subsidiary Eugia has been pulled up by the US Food and Drug Administration (USFDA) over manufacturing lapses at its...

Aurobindo Pharma arm gets marketing authorisation for Zefylti in EU

Aurobindo Pharma China plant expected to be commercialised from Q3 FY25: CFO

Ruchika Sharma20 Aug 2024 2:28 PM IST

New Delhi: Hyderabad-based pharmaceutical company, Aurobindo Pharma anticipates that its China facility will begin production in the upcoming...

USFDA issues warning letter to Aurobindo Pharma arm Unit III

Ruchika Sharma16 Aug 2024 11:30 AM IST

Hyderabad: Aurobindo Pharma has informed in a BSE filing that the US Food and Drug Administration (USFDA) has issued a warning letter for...

Aurobindo Pharma net profit increases 61 percent to Rs 919 crore in Q1

Ruchika Sharma12 Aug 2024 1:07 PM IST

New Delhi: Aurobindo Pharma has announced a 61 percent year-on-year increase in its consolidated net profit for the first quarter ended June...

Alembic Pharma gets USFDA EIR for Panelav facility

Aurobindo Pharma secures USFDA okay for generic version of Novo Nordisk Vagifem

Ruchika Sharma7 Aug 2024 11:30 AM IST

Hyderabad: Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to...

USFDA classifies Aurobindo Pharma arm Bhiwadi facility as OAI

Ruchika Sharma6 Aug 2024 12:30 PM IST

Hyderabad: Aurobindo Pharma has announced that the United States Food and Drug Administration (US FDA) has determined the inspection...

Aurobindo Pharma arm Eugia Pharma Specialities gets USFDA nod for cancer drug

Aurobindo Pharma arm buys Ace Lab for Rs 17.91 crore

Ruchika Sharma29 Jun 2024 3:13 PM IST

Hyderabad: Aurobindo Pharma has informed in a BSE filing that Agile Pharma BV, The Netherlands, a wholly owned step-down subsidiary of the...

Aurobindo Pharma arm Telangana injectable unit gets USFDA VAI classification

Ruchika Sharma27 Jun 2024 3:03 PM IST

Telangana: Aurobindo Pharma has informed in a BSE filing that the injectable facility of Eugia SEZ Pvt. Ltd., a 100 per cent step-down subsidiary...

Lupin recalls over 2000 bottles of antidepressant medication in US

Lupin, Aurobindo Pharma unit recall products from US over manufacturing issues

Ruchika Sharma24 Jun 2024 3:15 PM IST

New Delhi: According to the US health regulator, Lupin and a unit of Aurobindo Pharma are recalling products from the American market over...

Aurobindo Pharma unit partners with MSD to foray into contract manufacturing operations

Ruchika Sharma3 Jun 2024 12:42 PM IST

Hyderabad: Drug firm, Aurobindo Pharma has said that TheraNym Biologics, a wholly-owned subsidiary of the Company and an affiliate of...

Jubilant Pharmova arm Salisbury facility gets USFDA EIR

Aurobindo Pharma arm Unit III facility gets USFDA OAI status

Ruchika Sharma25 May 2024 12:32 PM IST

Hyderabad: Through a recent BSE filing, Aurobindo Pharma has informed that the United States Food and Drug Administration (US FDA) has determined...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok